John M. Ringman, MD, MS

Professor of Clinical Neurology

Helene and Lou Galen Endowed Professorship in Neurology

Image of John M. Ringman, MD, MS
Is this your profile? Click to edit

Research Funding

  • Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
    NIH · U01NS100614 · Sep 30, 2021 – Jul 31, 2026 · Role: Co-Principal Investigator
  • Phenotype and Genotype of Autosomal Dominant Alzheimer's Disease in Jalisco, Mexico
    NIH · R01AG069013 · Sep 15, 2020 – May 31, 2025 · Role: Principal Investigator
  • Motor, Visual, and Olfactory Changes in Genetic Subtypes of Alzheimer?s Disease
    NIH · R01AG062007 · Feb 15, 2019 – Nov 30, 2024 · Role: Principal Investigator
  • Validation of Imaging and Blood-based Small Vessel VCID Biomarkers in Multiethnic Population
    NIH · UF1NS100614 · Sep 30, 2016 – Jul 31, 2023 · Role: Co-Principal Investigator
  • Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
    NIH · UH3NS100614 · Sep 30, 2016 – Jul 31, 2021 · Role: Co-Principal Investigator
  • Imaging Cerebral and Retinal Microvasculature in Cerebral Small Vessel Disease
    NIH · UH2NS100614 · Sep 30, 2016 – Jul 31, 2018 · Role: Co-Principal Investigator
  • The structural and functional connectome across Alzheimer's disease subtypes
    NIH · U01AG051218 · Sep 30, 2015 – Jun 30, 2021 · Role: Principal Investigator
  • Establishing Infrastructure for Prevention of familial AD in Mexico
    NIH · R21TW009787 · Sep 1, 2013 – Apr 30, 2018 · Role: Principal Investigator
  • FMRI in Pre-Symptomatic PS1-related Alzheimer's Disease
    NIH · K08AG022228 · Aug 1, 2003 – Jul 31, 2007 · Role: Principal Investigator
  • UCLA Alzheimer's Disease Research Center
    NIH · P50AG016570 · Apr 5, 1999 – Mar 31, 2016 · Role: Co-Principal Investigator

Publications

  • Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease. Front Neurosci. 2021; 15:627627.. View in PubMed
  • Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease. Neurology. 2021 03 23; 96(12):e1632-e1645.. View in PubMed
  • MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols. Alzheimers Dement. 2021 04; 17(4):704-715.. View in PubMed
  • Past, present and future role of retinal imaging in neurodegenerative disease. Prog Retin Eye Res. 2021 07; 83:100938.. View in PubMed
  • Volumetric distribution of perivascular space in relation to mild cognitive impairment. Neurobiol Aging. 2021 03; 99:28-43.. View in PubMed
  • Reaction time and response inhibition in autosomal dominant Alzheimer’s disease. Brain Cogn. 2021 02; 147:105656.. View in PubMed
  • Autosomal dominant early onset Alzheimer’s disease in the Mexican state of Jalisco: High frequency of the mutation PSEN1 c.1292C>A and phenotypic profile of patients. Am J Med Genet C Semin Med Genet. 2020 12; 184(4):1023-1029.. View in PubMed
  • Comparison Between Blood-Brain Barrier Water Exchange Rate and Permeability to Gadolinium-Based Contrast Agent in an Elderly Cohort. Front Neurosci. 2020; 14:571480.. View in PubMed
  • Emotional detachment, gait ataxia, and cerebellar dysconnectivity associated with compound heterozygous mutations in the SPG7 gene. Neurocase. 2020 10; 26(5):299-304.. View in PubMed
  • A probabilistic atlas of locus coeruleus pathways to transentorhinal cortex for connectome imaging in Alzheimer’s disease. Neuroimage. 2020 12; 223:117301.. View in PubMed